DOI:
10.1055/s-00000036
Laryngo-Rhino-Otologie
LinksClose Window
References
Logunov DY, Dolzhikova IV, Shcheblyakov DV. et al.
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.
Lancet (London, England) 2021;
397: 671-681
DOI: 10.1016/S0140-6736(21)00234-8.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.